| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084920101 |
| P356 | DOI | 10.1038/SREP46366 |
| P932 | PMC publication ID | 5394470 |
| P698 | PubMed publication ID | 28417956 |
| P50 | author | Marcel Kool | Q90637389 |
| Peter Siesjö | Q55221651 | ||
| Gabriel Gallo-Oller | Q63979399 | ||
| Julio Enríquez Pérez | Q87852977 | ||
| Malin Wickström | Q42609796 | ||
| P2093 | author name string | Anna Darabi | |
| Cecilia Krona | |||
| Edward Visse | |||
| John Inge Johnsen | |||
| Emma Sandén | |||
| Tomas J Ekström | |||
| Thale Kristin Olsen | |||
| Cecilia Dyberg | |||
| Atosa Estekizadeh | |||
| P2860 | cites work | Molecular subgroups of medulloblastoma: the current consensus | Q24615271 |
| Dissecting the genomic complexity underlying medulloblastoma | Q24621907 | ||
| Murine models to evaluate novel and conventional therapeutic strategies for cancer | Q24673595 | ||
| In vitro models of medulloblastoma: Choosing the right tool for the job | Q26738711 | ||
| VEGF Manipulation in Glioblastoma | Q26782692 | ||
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition | Q27852966 | ||
| Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
| BET bromodomain inhibition as a therapeutic strategy to target c-Myc | Q28247024 | ||
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes | Q28271811 | ||
| Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Q29615823 | ||
| Comprehensive analysis of DNA methylation data with RnBeads | Q30855530 | ||
| Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
| Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays | Q33593399 | ||
| NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer | Q33655771 | ||
| The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. | Q33737469 | ||
| A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo | Q34132933 | ||
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
| Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics | Q43631246 | ||
| Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts | Q43671177 | ||
| Tumor-associated macrophages in SHH subgroup of medulloblastomas | Q46117209 | ||
| Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells | Q46841906 | ||
| Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts | Q47951778 | ||
| Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas | Q48748937 | ||
| Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. | Q55466712 | ||
| Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy | Q57565129 | ||
| Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells | Q70232420 | ||
| Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma | Q34362028 | ||
| The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis | Q34411509 | ||
| Higher susceptibility of NOD/LtSz-scid Il2rg (-/-) NSG mice to xenotransplanted lung cancer cell lines | Q34415301 | ||
| Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. | Q34554842 | ||
| Medulloblastoma subgroups remain stable across primary and metastatic compartments | Q35099027 | ||
| Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors | Q35602571 | ||
| Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. | Q35696355 | ||
| COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset | Q35818767 | ||
| A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays | Q35860191 | ||
| Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma | Q35914511 | ||
| MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties | Q35925281 | ||
| MethPed: an R package for the identification of pediatric brain tumor subtypes | Q36066534 | ||
| Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity. | Q36134167 | ||
| Novel mutations target distinct subgroups of medulloblastoma. | Q36143877 | ||
| CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer | Q36228506 | ||
| Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme | Q36413742 | ||
| Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses | Q36591942 | ||
| Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials | Q36622291 | ||
| Origin of the vasculature supporting growth of primary patient tumor xenografts | Q36863454 | ||
| Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma. | Q37040617 | ||
| Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets | Q37152015 | ||
| Characterization of distinct immunophenotypes across pediatric brain tumor types | Q37308164 | ||
| Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche | Q37433709 | ||
| Cytogenetic prognostication within medulloblastoma subgroups | Q37627692 | ||
| Collaborating with the enemy: function of macrophages in the development of neoplastic disease. | Q38098161 | ||
| Anti-angiogenic therapy in pediatric brain tumors: an effective strategy? | Q38156302 | ||
| Macrophage polarization in pathology | Q38554081 | ||
| Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells | Q38935879 | ||
| COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. | Q38981326 | ||
| Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas | Q39023964 | ||
| Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors. | Q39062141 | ||
| Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages | Q39225975 | ||
| Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma | Q40428404 | ||
| Karyotypic complexity of the NCI-60 drug-screening panel. | Q40604171 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | medulloblastoma | Q1333608 |
| P304 | page(s) | 46366 | |
| P577 | publication date | 2017-04-18 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation | |
| P478 | volume | 7 |
| Q92326554 | Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth |
| Q39446793 | Medulloblastoma: experimental models and reality |
| Q93039110 | Modeling medulloblastoma in vivo and with human cerebellar organoids |
| Q92862783 | Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy? |
| Q42362521 | Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System |
| Q92705351 | Preclinical Models of Craniospinal Irradiation for Medulloblastoma |
| Q63976777 | Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation |
Search more.